Prostate Cancer
Showing NaN - NaN of 98
Prostate Cancer Trial in Portland (Fluciclovine PET/CT)
Not yet recruiting
- Prostate Cancer
- Fluciclovine PET/CT
-
Portland, OregonOreogn Health & Science University
Feb 1, 2023
Prostate Cancer Trial in Worldwide (talazoparib plus enzalutamide, Placebo plus enzalutamide)
Recruiting
- Prostate Cancer
- talazoparib plus enzalutamide
- Placebo plus enzalutamide
-
Birmingham, Alabama
- +306 more
Jan 18, 2023
Prostate Cancer Trial in United States (ARN-509 (Phase 1), ARN-509 (Phase 2))
Active, not recruiting
- Prostate Cancer
- ARN-509 (Phase 1)
- ARN-509 (Phase 2)
-
San Diego, California
- +14 more
Jan 17, 2023
Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)
Recruiting
- Small Cell Lung Cancer
- +8 more
- ladiratuzumab vedotin
- pembrolizumab
-
Chandler, Arizona
- +65 more
Dec 19, 2022
Prostate Cancer Trial in Canada, United States (Enzalutamide, EPI-7386 with Enzalutamide)
Recruiting
- Prostate Cancer
- Enzalutamide
- EPI-7386 with Enzalutamide
-
Port Saint Lucie, Florida
- +8 more
Dec 13, 2022
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Validation for Early Cancer Detection and Minimal Residual
Recruiting
- Brain Cancer
- +19 more
-
Duarte, California
- +6 more
Nov 10, 2022
Prostate Cancer Trial in Worldwide (Standard of Care)
Recruiting
- Prostate Cancer
- Standard of Care
-
Birmingham, Alabama
- +107 more
Aug 17, 2022
Prostate Cancer Trial in Canada, United States (bicalutamide, radiation therapy, )
Prostate Cancer Trial in Portland (Intensity-Modulated Radiation Therapy (IMRT), Docetaxel+IMRT)
Active, not recruiting
- Prostate Cancer
- Intensity-Modulated Radiation Therapy (IMRT)
- Docetaxel+IMRT
-
Portland, Oregon
- +1 more
Apr 19, 2022
Prostate Cancer Trial in United States (Clinical Order Check, Academic Detailing, Audit and Feedback)
Active, not recruiting
- Prostate Cancer
- Clinical Order Check
- +2 more
-
Palo Alto, California
- +10 more
Mar 7, 2022
Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)
Recruiting
- Prostate Cancer
- Radiation Therapy
- +3 more
-
Gilbert, Arizona
- +107 more
Mar 17, 2022
Prostatic Tumors, Prostatic Diseases, Prostate Cancer Trial in Portland (68GA PSMA-HBED-CC)
Approved for marketing
- Prostatic Neoplasms
- +4 more
- 68GA PSMA-HBED-CC
-
Portland, OregonOHSU Knight Cancer Institute
Mar 11, 2022
Pancreatic Cancer, Thyroid Cancer, Lung Cancer Trial in United States
Recruiting
- Pancreatic Cancer
- +49 more
-
Colorado Springs, Colorado
- +80 more
Feb 22, 2022
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
Genes, Environment, and Prostate Cancer Risk in or Without
Completed
- Hereditary Prostate Cancer
- Prostate Cancer
- DNA analysis
- +6 more
-
Portland, OregonVeterans Affairs Medical Center - Portland
Nov 9, 2021
Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)
Completed
- Metastatic Cancer
- Prostate Cancer
- atrasentan hydrochloride
- +3 more
-
Mobile, Alabama
- +553 more
Oct 8, 2021
Radiologically Guided Biopsies of mCRPC
Completed
- Prostate Cancer
- Image-Guided Biopsies
-
Davis, California
- +4 more
Sep 30, 2021
Prostate Cancer Trial in Mexico, United States (aglatimagene besadenovec, , valacyclovir)
Active, not recruiting
- Prostate Cancer
- aglatimagene besadenovec
- +2 more
-
Golden, Colorado
- +22 more
Apr 26, 2021
Prostate Cancer Trial in Argentina, United States (Sagopilone (ZK 219477) + prednisone)
Completed
- Prostate Cancer
- Sagopilone (ZK 219477) + prednisone
-
Fountain Valley, California
- +16 more
Apr 6, 2021